人工智能与大数据在检验医学临床数据中的应用
本文讨论临床实验室正从大批量低成本检测向以患者为中心的整合服务转变,医疗数据数字化使人工智能工具应用成为可能。实验室信息系统包含质控、EQA结果及检测时间等大数据特征数据,但标准化、 harmonization及监管伦理问题阻碍发展,需加强实验室与AI专家合作。
要点
- LIS数据含患者结果、室内质控、EQA及检测时间等,具大数据特征。
- AI与大数据在检验医学应用受限于知识技能缺乏及标准化不足。
- 需加强实验室与AI专家合作并规范流程以开发有价值的临床工具。
核心结论
- 临床实验室数字化转型为AI应用创造新场景,但标准化、监管伦理及知识技能不足制约发展。
研究设计与样本
- 本文为综述,检索范围未明确报告。
主要发现
- LIS可包含患者结果、室内质控、EQA结果及检测请求与采血时间等大数据特征数据。
- 这些数据具有体量、速度、多样性和真实性等大数据典型特征,潜在可用于患者诊疗价值生成。
- AI与大数据在检验医学领域进展缓慢,原因包括知识技能缺乏、标准化 harmonization 不足及监管伦理问题。
- 算法的数学假设不足以获得有用临床工具,尤其当生物学参数未在适当背景下评估时。
临床怎么用
- 加强实验室与AI专家合作,协调治理流程以促进有价值临床工具开发。
局限性
- 缺乏标准化、 harmonization 及监管伦理问题阻碍AI与大数据在检验医学的应用。
- 算法数学假设不足以获得有用临床工具,尤其当生物学参数未在适当背景下评估时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During the last few years, clinical laboratories have faced a sea change, from facilities producing a high volume of low-cost test results, toward a more integrated and patient-centered service. Parallel to this paradigm change, the digitalization of healthcare data has made an enormous quantity of patients' data easily accessible, thus opening new scenarios for the utilization of artificial intelligence (AI) tools. Every day, clinical laboratories produce a huge amount of information, of which patients' results are only a part. The laboratory information system (LIS) may include other "relevant" compounding data, such as internal quality control or external quality assessment (EQA) results, as well as, for example, timing of test requests and of blood collection and exams transmission, these data having peculiar characteristics typical of big data, as volume, velocity, variety, and veracity, potentially being used to generate value in patients' care. Despite the increasing interest expressed in AI and big data in laboratory medicine, these topics are approaching the discipline slowly for several reasons, attributable to lack of knowledge and skills but also to poor or absent standardization, harmonization and problematic regulatory and ethical issues. Finally, it is important to bear in mind that the mathematical postulation of algorithms is not sufficient for obtaining useful clinical tools, especially when biological parameters are not evaluated in the appropriate context. It is therefore necessary to enhance cooperation between laboratory and AI experts, and to coordinate and govern processes, thus favoring the development of valuable clinical tools.
引用
- Padoan A, Plebani M. Flowing through laboratory clinical data: the role of artificial intelligence and big data. Clin Chem Lab Med. 2022. PMID: 35850928. doi:10.1515/cclm-2022-0653
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。